Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah Layton

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Drug Safety|June 28, 2014
Indicators of drug-seeking aberrant behaviours: the feasibility of use in observational post-marketing cohort studies for risk managementDeborah Layton, Vicki Osborne, Mohammad Al-Shukri, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|June 4, 2016
Utilisation and Tolerability of Aliskiren in the Primary Care Setting in EnglandAbigail L Coughtrie, Claire Doe, Deborah Layton, et al.
Drug Safety|May 23, 2020
A Framework for Methodological Choice and Evidence Assessment for Studies Using External Comparators from Real-World DataChristen M Gray, Fiona Grimson, Deborah Layton, et al.
Journal of Psychopharmacology (Oxford, England)|September 17, 2005
Comparison of incidence rates of cerebrovascular accidents and transient ischaemic attacks in observational cohort studies of patients prescribed risperidone, quetiapine or olanzapine in general practice in England including patients with dementiaDeborah Layton, Scott Harris, Lynda V Wilton, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 17, 2004
Safety profile of raloxifene as used in general practice in England: results of a prescription-event monitoring studyDeborah Layton, Andrea Clarke, Lynda V Wilton, et al.
Drug Safety|August 27, 2005
A comparison of reported gastrointestinal and thromboembolic events between rofecoxib and celecoxib using observational dataRachna Kasliwal, Deborah Layton, Scott Harris, et al.
British Journal of Clinical Pharmacology|June 21, 2005
Deep vein thrombosis and pulmonary embolism reported in the Prescription Event Monitoring Study of YasminHilary M Pearce, Deborah Layton, Lynda V Wilton, et al.
Drug Safety|January 23, 2016
Safety of Intranasal Quadrivalent Live Attenuated Influenza Vaccine (QLAIV) in Children and Adolescents: A Pilot Prospective Cohort Study in EnglandRhian McNaughton, Elizabeth Lynn, Vicki Osborne, et al.
Drug Safety|June 18, 2010
Incidence of venous thromboembolism in users of strontium ranelate: an analysis of data from a prescription-event monitoring study in EnglandVicki Osborne, Deborah Layton, Michael Perrio, et al.
Frontiers in Pharmacology|June 29, 2023
Identification of cardiotoxicity related to non-small cell lung cancer (NSCLC) treatments: A systematic reviewStefanie Ho Yi Chan, Yasmin Khatib, Sherael Webley, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Drug Safety|June 28, 2014
Indicators of drug-seeking aberrant behaviours: the feasibility of use in observational post-marketing cohort studies for risk managementDeborah Layton, Vicki Osborne, Mohammad Al-Shukri, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|June 4, 2016
Utilisation and Tolerability of Aliskiren in the Primary Care Setting in EnglandAbigail L Coughtrie, Claire Doe, Deborah Layton, et al.
Drug Safety|May 23, 2020
A Framework for Methodological Choice and Evidence Assessment for Studies Using External Comparators from Real-World DataChristen M Gray, Fiona Grimson, Deborah Layton, et al.
Journal of Psychopharmacology (Oxford, England)|September 17, 2005
Comparison of incidence rates of cerebrovascular accidents and transient ischaemic attacks in observational cohort studies of patients prescribed risperidone, quetiapine or olanzapine in general practice in England including patients with dementiaDeborah Layton, Scott Harris, Lynda V Wilton, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 17, 2004
Safety profile of raloxifene as used in general practice in England: results of a prescription-event monitoring studyDeborah Layton, Andrea Clarke, Lynda V Wilton, et al.
Drug Safety|August 27, 2005
A comparison of reported gastrointestinal and thromboembolic events between rofecoxib and celecoxib using observational dataRachna Kasliwal, Deborah Layton, Scott Harris, et al.
British Journal of Clinical Pharmacology|June 21, 2005
Deep vein thrombosis and pulmonary embolism reported in the Prescription Event Monitoring Study of YasminHilary M Pearce, Deborah Layton, Lynda V Wilton, et al.
Drug Safety|January 23, 2016
Safety of Intranasal Quadrivalent Live Attenuated Influenza Vaccine (QLAIV) in Children and Adolescents: A Pilot Prospective Cohort Study in EnglandRhian McNaughton, Elizabeth Lynn, Vicki Osborne, et al.
Drug Safety|June 18, 2010
Incidence of venous thromboembolism in users of strontium ranelate: an analysis of data from a prescription-event monitoring study in EnglandVicki Osborne, Deborah Layton, Michael Perrio, et al.
Frontiers in Pharmacology|June 29, 2023
Identification of cardiotoxicity related to non-small cell lung cancer (NSCLC) treatments: A systematic reviewStefanie Ho Yi Chan, Yasmin Khatib, Sherael Webley, et al.
Pageof 6